On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
et al., Annals of Oncology, doi:10.1016/j.annonc.2020.06.005, Oct 2020
7th treatment shown to reduce risk in
September 2020, now with p = 0.000000056 from 49 studies.
No treatment is 100% effective. Protocols
combine treatments.
6,300+ studies for
210+ treatments. c19early.org
|
Retrospective study of 1,949 metastatic prostate cancer patients on androgen deprivation therapy in Italy. The study found a 1.8% SARS-CoV-2 infection rate and 30.6% mortality among infected patients. Patients were elderly with metastatic castrate-resistant disease, which may explain the high mortality rate. There was no control group, so no conclusions can be made about any potential protective or harmful effect of ADT on COVID-19 infection risk or outcomes.
Caffo et al., 31 Oct 2020, retrospective, Italy, peer-reviewed, 20 authors.
Contact: mariaadoracion.romaguera@ssib.es.
DOI record:
{
"DOI": "10.1016/j.annonc.2020.06.005",
"ISSN": [
"0923-7534"
],
"URL": "http://dx.doi.org/10.1016/j.annonc.2020.06.005",
"alternative-id": [
"S0923753420398926"
],
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "Annals of Oncology"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.annonc.2020.06.005"
},
{
"label": "Content Type",
"name": "content_type",
"value": "simple-article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 European Society for Medical Oncology. Published by Elsevier Ltd."
}
],
"author": [
{
"affiliation": [],
"family": "Caffo",
"given": "O.",
"sequence": "first"
},
{
"affiliation": [],
"family": "Zagonel",
"given": "V.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Baldessari",
"given": "C.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Berruti",
"given": "A.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bortolus",
"given": "R.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Buti",
"given": "S.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ceresoli",
"given": "G.L.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Donini",
"given": "M.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ermacora",
"given": "P.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Fornarini",
"given": "G.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Fratino",
"given": "L.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Masini",
"given": "C.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Massari",
"given": "F.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Mosca",
"given": "A.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Mucciarini",
"given": "C.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Procopio",
"given": "G.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tucci",
"given": "M.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Verri",
"given": "E.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Zucali",
"given": "P.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Buttigliero",
"given": "C.",
"sequence": "additional"
}
],
"container-title": "Annals of Oncology",
"container-title-short": "Annals of Oncology",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"annalsofoncology.org",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
6,
18
]
],
"date-time": "2020-06-18T01:42:10Z",
"timestamp": 1592444530000
},
"deposited": {
"date-parts": [
[
2021,
10,
5
]
],
"date-time": "2021-10-05T07:04:11Z",
"timestamp": 1633417451000
},
"indexed": {
"date-parts": [
[
2024,
1,
10
]
],
"date-time": "2024-01-10T14:20:22Z",
"timestamp": 1704896422770
},
"is-referenced-by-count": 31,
"issue": "10",
"issued": {
"date-parts": [
[
2020,
10
]
]
},
"journal-issue": {
"issue": "10",
"published-print": {
"date-parts": [
[
2020,
10
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
10,
1
]
],
"date-time": "2020-10-01T00:00:00Z",
"timestamp": 1601510400000
}
},
{
"URL": "http://www.elsevier.com/open-access/userlicense/1.0/",
"content-version": "vor",
"delay-in-days": 365,
"start": {
"date-parts": [
[
2021,
10,
1
]
],
"date-time": "2021-10-01T00:00:00Z",
"timestamp": 1633046400000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0923753420398926?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0923753420398926?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "1415-1416",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2020,
10
]
]
},
"published-print": {
"date-parts": [
[
2020,
10
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/j.annonc.2020.04.479",
"article-title": "Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)",
"author": "Montopoli",
"doi-asserted-by": "crossref",
"first-page": "1040",
"issue": "8",
"journal-title": "Ann Oncol",
"key": "10.1016/j.annonc.2020.06.005_bib1",
"volume": "31",
"year": "2020"
}
],
"reference-count": 1,
"references-count": 1,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0923753420398926"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Oncology",
"Hematology"
],
"subtitle": [],
"title": "On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "31"
}